Skip to main content

Advertisement

SpringerLink
Log in

PATENTS

The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape

  • Patents
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Global patents in the field of CAR-T cell therapy show a changing landscape with fierce competition and intensive collaboration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Flow diagram of patent sample.
Fig. 2: Collaboration networks of CAR-T patents.
Fig. 3: Publication trend of CAR-T patents.
Fig. 4
Fig. 5: Patent citation network on CAR-T.
Fig. 6: Milestone CAR-T patents.

References

  1. Hoos, A. Nat. Rev. Drug Discov. 15, 235–247 (2016).

    Article  CAS  Google Scholar 

  2. Tang, J., Pearce, L., O’Donnell-Tormey, J. & Hubbard-Lucey, V. M. Nat. Rev. Drug Discov. 17, 783–784 (2018).

    Article  CAS  Google Scholar 

  3. Tang, J., Hubbard-Lucey, V. M., Pearce, L., O’Donnell-Tormey, J. & Shalabi, A. Nat. Rev. Drug Discov. 17, 465–466 (2018).

    Article  CAS  Google Scholar 

  4. Yip, A. & Webster, R. M. Nat. Rev. Drug Discov. 17, 161–162 (2018).

    Article  CAS  Google Scholar 

  5. Centers for Medicare & Medicaid Services. Decision memo for chimeric antigen receptor (CAR) T-cell therapy for cancers (CAG-00451N) (2019); https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=291

  6. National Health Service England. NHS England announces groundbreaking new personalised therapy for children with cancer (2018). https://www.england.nhs.uk/2018/09/nhs-england-announces-groundbreaking-new-personalised-therapy-for-children-with-cancer/

  7. Ministry of Health, Labour and Welfare. Handling of regenerative medicine products on medical insurance (2019); https://www.mhlw.go.jp/stf/shingi2/0000212500_00025.html

  8. US Patent and Trademark Office. Case IPR2015-01719, Patent 7,446,190B2 (2015); https://www.ptablitigationblog.com/wp-content/uploads/2017/01/604105.pdf

  9. Jürgens, B. & Clarke, N. S. Nat. Biotechnol. 37, 370–375 (2019).

    Article  Google Scholar 

  10. Smith, J. A., Arshad, Z., Thomas, H., Carr, A. J. & Brindley, D. A. Nat. Biotechnol. 35, 210–214 (2017).

    Article  CAS  Google Scholar 

  11. Smith, J. A. et al. Nat. Biotechnol. 36, 1043–1047 (2018).

    Article  CAS  Google Scholar 

  12. Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Ann. Intern. Med. 151, 264–269 (2009). W64.

    Article  Google Scholar 

  13. European Patent Office: INPADOC extended patent family. https://www.epo.org/searching-for-patents/helpful-resources/first-time-here/patent-families/inpadoc.html (accessed 25 May 2020).

  14. Porter, D. L., Levine, B. L., Kalos, M., Bagg, A. & June, C. H. N. Engl. J. Med. 365, 725–733 (2011).

    Article  CAS  Google Scholar 

  15. Kochenderfer, J. N. et al. Blood 116, 4099–4102 (2010).

    Article  CAS  Google Scholar 

  16. Ruella, M. & June, C. H. Curr. Hematol. Malig. Rep. 11, 368–384 (2016).

    Article  Google Scholar 

  17. Egelie, K. J., Graff, G. D., Strand, S. P. & Johansen, B. Nat. Biotechnol. 34, 1025–1031 (2016).

    Article  CAS  Google Scholar 

  18. Tralau-Stewart, C. J., Wyatt, C. A., Kleyn, D. E. & Ayad, A. Drug Discov. Today 14, 95–101 (2009).

    Article  Google Scholar 

  19. Feldmann, M. & Maini, R. N. Nat. Med. 9, 1245–1250 (2003).

    Article  CAS  Google Scholar 

  20. Dolgin, E. Nat. Biotechnol. 35, 891–892 (2017).

    Article  CAS  Google Scholar 

  21. Ahuja, G. & Katila, R. Strateg. Manage. J. 22, 197–220 (2001).

    Article  Google Scholar 

  22. Rikap, C. Rev. Int. Polit. Econ. 26, 987–1021 (2019).

    Article  Google Scholar 

  23. Martin-Laffon, J., Kuntz, M. & Ricroch, A. E. Nat. Biotechnol. 37, 613–620 (2019).

    Article  CAS  Google Scholar 

  24. Raje, N. et al. N. Engl. J. Med. 380, 1726–1737 (2019).

    Article  CAS  Google Scholar 

  25. Yan, Z. et al. Lancet Haematol. 6, 521–529 (2019).

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank J. Smith from NDORMS, the University of Oxford, for insightful comments and G. Li from IQVIA for assisting with data processing. We are grateful to the University of Macau Library for providing effective data service and the University of Macau for financial support via the project MYRG2019-00011-ICMS.

Author information

Authors and Affiliations

  1. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China

    Liyang Lyu, Ye Feng, Xin Chen & Yuanjia Hu

Authors
  1. Liyang Lyu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ye Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuanjia Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuanjia Hu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Supplementary information

Supplementary Information

Supplementary Note, Figs. 1–5 and Tables 1–7

Supplementary Data

Spreadsheet of 12,431 patent documents included in study

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lyu, L., Feng, Y., Chen, X. et al. The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape. Nat Biotechnol 38, 1387–1394 (2020). https://doi.org/10.1038/s41587-020-00749-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-020-00749-8

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation